GLORY announces the suspension of Serge Maslobojev for violations of the GLORY Anti-Doping Rules (“ADR”) as a result of two positives samples collected out-of-competition and in-competition on 14 June 2025 at GLORY 100. All of the sample were analyzed at a World Anti-Doping Agency (WADA) accredited laboratory.
Maslobojev tested positive for a metabolite of stanozolol, a prohibited substance in the class of Anabolic Agents on the WADA Prohibited List, which is incorporated into the GLORY ADR.
Based on the evidence provided and the circumstances of his case, including his eligibility for a reduction due to his full and complete cooperation, Maslobojev received a 12-month suspension beginning on 14 June 2025, the date his sample was collected.
Although Maslobojev previously vacated the light-heavyweight title that he earned at GLORY 100, the results from the event and now been officially declared a no-contest. In addition, GLORY has imposed financial consequences in accordance with the rules.